Literature DB >> 17719423

Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.

Robert E McMahon, Jerry E Bouquot, Charles J Glueck, John A Griep, William R Adams, Kenneth J Spolnik, Kevin A Deardorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17719423     DOI： 10.1016/j.joms.2007.04.021

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  5 in total

Review 1.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

Review 2.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

3.  Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Authors:  N Ersan; L J van Ruijven; A L J J Bronckers; V Olgaç; D Ilgüy; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

Review 4.  Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature.

Authors:  C Gavaldá; J-V Bagán
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01

Review 5.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.